Benmoxin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Benmoxin
Benmoxin.svg
Clinical data
Routes of
administration
Oral
ATC code
  • None
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard 100.028.745
Chemical and physical data
Formula C15H16N2O
Molar mass 240.30 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]

See also[edit]

References[edit]

  1. ^ a b Ganellin, C. R.; Triggle, David J. (1996). Dictionary of Pharmacological Agents, Volumes 1-2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5. 
  2. ^ a b Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.